What is Alnylam Pharmaceuticals's roche license obligation — transaction price?

Alnylam Pharmaceuticals (ALNY) reported roche license obligation — transaction price of $675.00M in Q1 2026.

How has Alnylam Pharmaceuticals's roche license obligation — transaction price changed year-over-year?

Alnylam Pharmaceuticals's roche license obligation — transaction price increased by 80.0% year-over-year, from $375.00M to $675.00M.

Products & Services · Transaction price

Roche License Obligation — Transaction price

Alnylam Pharmaceuticals Roche License Obligation — Transaction price remained flat by 0.0% to $675.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 80.0%, from $375.00M to $675.00M.

Analysis

StatementSegment

First reportedQ3 2023

Last reportedQ1 2026

Metric ID: alny_segment_roche_license_obligation_transaction_price

Historical Data

7 periods

	Q3 '23	Q4 '23	Q4 '24	Q1 '25	Q2 '25	Q4 '25	Q1 '26
Value	$310.00M	$310.00M	$375.00M	$375.00M	$675.00M	$675.00M	$675.00M
QoQ Change	—	+0.0%	+21.0%	+0.0%	+80.0%	+0.0%	+0.0%
YoY Change	—	—	+21.0%	—	—	+80.0%	+80.0%

Range$310.00M – $675.00M

CAGR+68.0%

Avg YoY Growth+60.3%

Median YoY Growth+80.0%

Current Streak6+ quarters growth

Frequently Asked Questions

What is Alnylam Pharmaceuticals's roche license obligation — transaction price?: Alnylam Pharmaceuticals (ALNY) reported roche license obligation — transaction price of $675.00M in Q1 2026.
How has Alnylam Pharmaceuticals's roche license obligation — transaction price changed year-over-year?: Alnylam Pharmaceuticals's roche license obligation — transaction price increased by 80.0% year-over-year, from $375.00M to $675.00M.